The Centers for Disease Control and Prevention (CDC) today released a report that finds a wide range of variation in the prevalence of coronary heart disease (a narrowing of the arteries that feed the heart), heart attack and angina (chest pain that occurs when the heart does not get enough blood).
The most important genes associated with a risk of developing type-2 diabetes have been identified, scientists report today in a new study.
Several of the nation?s top experts in pandemic, bioterrorism, and disaster readiness will be on hand next week at the premier annual gathering of preventive medicine and public health leaders to discuss public health preparedness and response efforts at the national, state, and local levels.
While previous biomedical research studies have found that genetics and race increase risk for some diseases, a new look into how researchers study genetic triggers of type 2 diabetes suggests that defining race remains an inexact science, with social and historic facts mixing with biology throughout the research process.
Federal legislation aimed at fighting the No. 1 killer of American women — heart disease, stroke and other cardiovascular diseases — today received the endorsement of several leading women’s heart and health care organizations.
Led by researchers at Weill Cornell Medical College in New York City, an international group of scientists has pinpointed a specific genetic relationship as the cause of dangerous iron overload in persons with a form of the inherited blood disease, beta-thalassemia.
University of Iowa researchers have learned more about a genetic variation that is a small risk factor for a mild form of schizophrenia yet also is associated with improved overall survival.
South Africa has one of the world?s highest rates of HIV infection. New research, led by Brown University professor Mark Lurie, shows that the movement of workers between urban and rural areas played a key role in the spread of the epidemic. Results are published in AIDS.
A CNRS team headed by Philippe Froguel (CNRS, University of Lille 2, Pasteur Institute, Imperial College London) and Rob Sladek (McGill University, Montreal, Canada) in a French-British-Canadian collaboration that accounts for about 70 percent of the genetic risk for patients with type two diabetes.
Changing the way women are treated for breast cancer could improve their overall chance of survival, according to research published today in the Lancet. The new paper shows that switching to a drug called exemestane, two to three years after commencing standard therapy with the drug tamoxifen, can cut the risk of death for certain women by a further 17 percent compared with using tamoxifen alone.